FDC Ltd Receives Favourable Income Tax Order With Rs 37.22 Crore Refund

Total refund amount stands at Rs 37.22 crore covering Assessment Years 2012-13 and 2014-15.
This cash inflow follows the successful resolution of long-standing tax disputes regarding publicity and research deductions.

Reader Takeaway: One-time cash inflow boosts liquidity, though it results from historical tax adjustments rather than core operational growth.

What just happened

FDC Ltd announced the receipt of favourable tax orders from the Assistant Commissioner of Income Tax, Mumbai. These orders resolve disputes involving tax disallowances for Assessment Years 2012-13 and 2014-15. The jurisdictional AO orders, received on October 30 and October 31, 2026, officially give effect to a prior ruling by the Commissioner of Income Tax (Appeals).

Why this matters

The resolution brings a direct cash inflow of Rs 37.22 crore to the company. Additionally, the interest income associated with this refund amount will be credited to the Statement of Profit and Loss. This serves as a positive non-operating income boost for the company in the relevant period, effectively closing out litigation matters that had been pending for over a decade.

The backstory

The dispute originated from tax disallowances made by the Assessing Officer concerning the company's expenditure on publicity and specific deductions claimed under section 35(2AB) of the Income Tax Act, 1961. FDC Ltd challenged these disallowances in appeal, and the final orders confirm that the company's submissions were accepted by the appellate authority.

What to track next

Investors should look for the reflection of this refund in the upcoming quarterly results, specifically under non-operating income. While this provides a short-term financial lift, it does not alter the company's core pharmaceutical business performance.